Ruthenium-peptide conjugates:

arrows for selectively targeting breast cancer

Arrows2cancer

Home

Goal

Team

News

Our publications

Papers in peer-reviewed international journals

Synthesis and Evaluation of Cytotoxic Activity of RuCp(II) Complexes Bearing (Iso)nicotinic Acid Based Ligands

Tailored Metal-Based Catalysts: A New Platform for Targeted Anticancer Therapies

Dual FGFR-Targeting and pH-Activatable Ruthenium–Peptide Conjugates for Targeted Therapy of Breast Cancer

Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer Agents

Copper(I)-Thiosemicarbazone Complexes with Dual Anticancer and Antiparasitic Activity

Design and Anticancer Properties of NewWater-Soluble Ruthenium–Cyclopentadienyl Complexes

Are smart delivery systems the solution to overcome the lack of selectivity of current metallodrugs in cancer therapy?

Ultrasonication Improves Solid Phase Synthesis of Peptides Specific for Fibroblast Growth Factor Receptor and for the Protein-Protein Interface RANK-TRAF6

Emerging Molecular Receptors for the Specific-Target Delivery of Ruthenium and Gold Complexes into Cancer Cells

Page updated

Google Sites

Report abuse